Selective expression of inhibitory Fcγ receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response-Reference-Cited by-同舟云学术

Selective expression of inhibitory Fcγ receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response

Published:2008-12-15 Issue:12 Volume:123 Page:2832-2839
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Cassard Lydie,Cohen-Solal Joel F.G.,Fournier Emilie M.,Camilleri-Broët Sophie,Spatz Alain,Chouaïb Salem,Badoual Cécile,Varin Audrey,Fisson Sylvain,Duvillard Pierre,Boix Charlotte,Loncar Shannon M.,Sastre-Garau Xavier,Houghton Alan N.,Avril Marie-Françoise,Gresser Ion,Fridman Wolf H.,Sautès-Fridman Catherine

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference56 articles.

1. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma;Clark;Hum Pathol,1984

2. Immunity against cancer: lessons learned from melanoma;Houghton;Curr Opin Immunol,2001

3. The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma;Anichini;Cancer Immunol Immunother,2004

4. 1975-1995 revised anti-cancer serological response: biological significance and clinical implications;Canevari;Ann Oncol,1996

5. Human neoplasms elicit multiple specific immune responses in the autologous host;Sahin;Proc Natl Acad Sci USA,1995

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential expression of plasma proteins in pregnant women exposed toPlasmodium falciparummalaria;2024-05-03

2. Pre-Operative Immunonutrition Enhances Postoperative Outcomes and Elevates Tumor-Infiltrating Lymphocyte Counts in Colorectal Cancer Patients: A Meta-Analysis of Randomized Controlled Trials;Nutrition and Cancer;2024-04-24

3. Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma;Frontiers in Oncology;2022-03-17

4. FcγRIIB is a T cell checkpoint in antitumor immunity;JCI Insight;2021-02-22

5. APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application;Cancer Immunology, Immunotherapy;2021-01-03